Poland· PL-100351067

Triveram

A atorvastatin, amlodipin und perindopril product containing atorvastatinum + perindoprilum argininum + amlodipinum, registered in Poland by Les Laboratoires Servier. The same ATC class is registered in 6 of our 19 countries.

ATC C10BX11

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedTriveramATCC10BX11REGISTER NO.PL-100351067PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Atorvastatin, amlodipin und perindopril is registered in 6 of 19 countries.

Countries holding a registration under ATC C10BX11 (atorvastatin, amlodipin und perindopril), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose

Atorvastatin, amlodipin und perindopril · ATC C10BX11

6 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Atorvastatinum + Perindoprilum argininum + Amlodipinum
Manufacturer
Les Laboratoires Servier
Country
Poland (PL)
ATC code
C10BX11
ATC class
Atorvastatin, Amlodipin und Perindopril
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05901571320441
  • gtin
    05901571320458

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Atorvastatin, amlodipin und perindopril in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All atorvastatin, amlodipin und perindopril products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b1e2a7c1-4382-4d55-85f4-a13b9a085e3b
GET /v1/drugs/b1e2a7c1-4382-4d55-85f4-a13b9a085e3b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "20 mg + 10 mg + 10 mg",
  "packaging": "05901571320441 ¦ Rp ¦ 112583\n30 tabl.\n05901571320458 ¦ Rp ¦ 112584\n90 tabl. (3 x 30)",
  "substance": "Atorvastatinum calcicum trihydricum 21.64 mg + Perindoprilum argininum 10 mg + Amlodipini besilas 13.87 mg",
  "common_name": "Atorvastatinum + Perindoprilum argininum + Amlodipinum",
  "pl_product_id": "100351067",
  "pozwolenie_nr": "22811",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about atorvastatin, amlodipin und perindopril.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.